Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Edwards Lifesciences Corporation

Edwards Lifesciences Corporation (EW) Stock Overview

Explore Edwards Lifesciences Corporation’s financial performance, market position, analyst ratings, and future outlook.

EW●NYSE
HealthcareMedical - Devices
$104.71
$2.57(2.52%)
U.S. Market opens in 15h 51m

Edwards Lifesciences Corporation (EW)

Meyka AI Score

Z

Key Financials

Market Cap60.4B
P/E Ratio57.36
EPS (TTM)$2.70
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$100.61
3 Months$92.37
1 Year Target$89.26

EW Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Edwards Lifesciences Corporation (NYSE: EW) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Edwards Lifesciences Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EW on the NYSE shows an RSI of 79.68, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $89.26 for the NYSE listing.

Key metrics behind Edwards Lifesciences Corporation's NYSE-traded stock include a P/E ratio of 57.36 and a market capitalization of 60.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of EW on the NYSE.

Price Performance (NYSE: EW)

1-Day Change
2.54%
5-Day Change
6.24%
1-Month Change
22.91%
3-Month Change
16.73%
6-Month Change
30.98%
Year-to-Date (YTD) Change
22.85%
1-Year Change
24.56%
3-Year Change
62.00%
5-Year Change
-12.75%
All-Time (Max) Change
7516.73%

Contact Information

https://www.edwards.com
949 250 2500
One Edwards Way, Irvine, CA, 92614

Company Facts

160,000 Employees
IPO DateMar 27, 2000
CountryUS
Actively Trading

Frequently Asked Questions